Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2

2010 New England Journal of Medicine 521 citations

Abstract

Daily acyclovir therapy did not reduce the risk of transmission of HIV-1, despite a reduction in plasma HIV-1 RNA of 0.25 log(10) copies per milliliter and a 73% reduction in the occurrence of genital ulcers due to HSV-2. (ClinicalTrials.gov number, NCT00194519.)

Keywords

Herpes simplex virusHSL and HSVMedicineVirologyTransmission (telecommunications)Human immunodeficiency virus (HIV)Genital herpesVirusHerpes GenitalisSex organImmunologyBiology

MeSH Terms

AIDS-Related Opportunistic InfectionsAcyclovirAdolescentAdultAntiviral AgentsCD4 Lymphocyte CountFemaleFollow-Up StudiesHIV InfectionsHIV-1Herpes GenitalisHerpesvirus 2HumanHumansIntention to Treat AnalysisKaplan-Meier EstimateMalePatient CompliancePregnancyRNAViralUnsafe SexYoung Adult

Related Publications

Publication Info

Year
2010
Type
letter
Volume
362
Issue
5
Pages
427-439
Citations
521
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

521
OpenAlex
14
Influential
427
CrossRef

Cite This

Connie Celum, Anna Wald, Jairam R. Lingappa et al. (2010). Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2. New England Journal of Medicine , 362 (5) , 427-439. https://doi.org/10.1056/nejmoa0904849

Identifiers

DOI
10.1056/nejmoa0904849
PMID
20089951
PMCID
PMC2838503

Data Quality

Data completeness: 86%